AXONIS Therapeutics is a biotechnology developing therapies for currently incurable neurological disorders. AXONIS Therapeutics is progressing a pipeline of neuron-reviving therapeutics which enable an intrinsic ability of central nervous system (CNS) neurons to resist degeneration; restore excitation/inhibition balance; and regenerate.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
07/14/21 | $5,000,000 |
Alexandria Venture Investments BoxOne Ventures Christopher & Dana Reeve Foundation Civilization Ventures R3 Bio Spinal Research | undisclosed |